Синтез и биологические свойства конъюгатов полиэдрических гидридов бора с нуклеозидами (1091861), страница 21
Текст из файла (страница 21)
– P. 749-756.30Mourier N. S., Eleuteri A., Hurwitz S. J., Tharnish P. M. and Schinazi R. F.Enantioselective SynthesisandBiologicalEvaluationof 5-o-CarboranylPyrimidine Nucleosides, Bioorg. and MedChem. – 1999. – V. 7. – P. 2759-2766.31Goudgaon N. M., Kattan El.Y., Xia X., McAtee J., Soria J., Wey S.-J., LiottaD.C., Schinazi R. F. Nonisothermal particle modeling of municipal solid wastecombustion with heavy metal vaporization // Nucleosides Nucleotides.
– 1997. –V. 16. – P. 2133-2150.32Holy A. A synthesis of 2’-deoxy-l-uridine // Tetrahedron Lett. – 1971. – V. 2. –P. 189-192.33Hampton A., Nichol A.W. Purine Ribonucleoside 2’,3’-Cyclic CarbonatesPreparation and Use for the Synthesis of 5’-Monosubstituted Nucleosides //Biochemistry. – 1966. – V. 5. – P. 2076-2082.34Imamura K. and Yamamoto Y. Sinthesis and in vitro evaluation of sugar-modified carboranyluridines // Bioorganic and Medicinal Chemistry Letters. –1996.
– V. 6. – №15. – P. 1855-1858.35Kattan G.F.E., Goudgaon N.M., Ilksoy N., Huang J.T., Watanade K.A.,Sommadossi J.P., Schinazi R.F. Synthesis and Biolgical Properties of 5-oCarboranyl-1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)uracil // J. Med. Chem. –1994. – V. 37.
– P. 2583-2588.36Tjarks W., Anisuzzaman A.K.M., Liu L., Soloway A.H., Barth R.F., Perkin D.J.,and Adams D.A. Synthesis and in vitro evaluation of boronateduridine and glucosederivatives for boron neutron capture therapy // J. Med. Chem. – 1992. – V. 35. –P. 1628–1633.14337Rond F.-G., Soloway A. H. Synthesis of 5-Tethered Carborane-ContainingPyrimidine Nucleosides as Potential Agents for DNA Incorporation // Nucleosidesand Nucleotides.
– 1994. – V. 13(9). – P. 2021-2034.38Rond F.-G., Soloway A. H., Ikeda S., Ives D.H. Synthesis and BiochemicalActivity of 5-Tethered Carborane-Containing Pyrimidine Nucleosides as PotentialAgents for DNA Incorporation // Nucleosides and Nucleotides. – 1994. – V. 14(910). – P. 1873-1887.39Kabalka G.W., Kesavulu R.N., Harayana C. In Cancer Neutron Capture therapy// Y.Ed.
Mishima, Plenum Press, New York. – 1996. – P. 156-161.40Byun Y., Yan J., Al – Madhoun A.S., Johnsamuel J., Yang W., Barth R.F.,Eriksson S., Tjarks W. Synthesis and Biological Evaluation of Neutral andZwitterionic 3-Carboranyl Thymidine Analogues for Boron Neutron CaptureTherapy // J. Med. Chem. – 2005. – V.
48. – P. 1188-1198.41Byun Y., Yan J., Al-Madhoun A.S., Johnsamuel J., Yang W., Barth R. F.,Eriksson S., Tjarks W.. The synthesis and biochemical evaluation ofthymidineanalogues substituted with nidocarborane at the N-3 position // Applied Radiationand Isotopes. – 2004. – V. 61. – P.
1125–1130.42Al Madhoun A.S., Johnsamuel J., Yan J., Ji W., Wang J., Zhuo J.-C., LunatoA.J., Woollard J.E., Hawk A.E., Cosquer G.Y., Blue T.E., Eriksson S. and TjarksW. Synthesis of a Small Library of 3-(Carboranylalkyl)thymidines and TheirBiological Evaluation as Substrates for Human Thymidine Kinases 1 and 2 // J.Med. Chem. – 2002. – V.
45. – P. 4018-4028.43Byun Y., Thirumamagal B. T. S., Yang W., Eriksson S., Barth R.F. and TjarksW. Preparation and Biological Evaluation ofB-Enriched 3-[5-{2-(2,3-10Dihydroxyprop-1-yl)-o-carboran-1yl}pentan-1-yl]thymidine (N5-2OH), a NewBoron Delivery Agent for Boron Neutron Capture Therapy of Brain Tumors // J.Med. Chem. – 2006. – V. 49. – P.
5513-5523.14444Kusari U., Li Y., Bradley M.G., Sneddon L.G. Polyborane reactions in ionicliquids: new efficient routes to functionalized decaborane and o-carborane clusters// J. Am. Chem. Soc. – 2004. – V.126. – P. 8662-8663.45Busby D.C., Hawthorne M.F. The Crown Ether Promoted Base Degradation ofp-Carborane // Inorg.Chem. – 1982. – V. 21. – P. 4101.46S.
Narayanasamy, B.T.S. Thirumamagal, Johnsamuel J., Byun Y., Al MadhounA.S., Usova E., Cosquer G.Y., Yan J., Bandyopadhyaya A.K., Tiwari R.,Erikssonc S. and Tjarks W. Hydrophilically enhanced 3-carboranyl thymidineanalogues (3CTAs) for boron neutron capture therapy (BNCT) of cancer // Bioorg.Med.
Chem. – 2006. – V. 14. – P. 6886-6899.47Davoli P., Spaggiari A., Castagnetti L., Prati F. Total synthesis ofmicrocarpalide, a novel microfilament disrupting metabolite // Org. Biomol. Chem.– 2004. – V. 2. – P. 38-47.48Vlieghe P., Clerc T., Pannecouque C., Witvrouw M., De Clercq E., Salles J.-P.,KrausJ.-L.New3’-azido-3’-deoxythymidin-5’-yl-O-(ω-hydroxyalkyl)carbonateprodrugs: synthesis and anti-HIV evaluation // J.
Med. Chem. – 2001. –V. 44. – P. 777-786.49Lee A.S.-Y., Yeh H.C., Tsai M.H. A simple and highly chemoselectivedesilylation of tert-butyldimethylsilyl ethers // Tetrahedron Lett. – 1995. – V. 36. –P. 6891-6894.50Wojtczak B., Semenyuk A., Olejniczak A.B., Kwiatkowski M. and LesnikowskiZ.J. General method for the synthesis of 2’-O-carboranyl-nucleosides //Tetrahedron Let. – 2005. – V. 46. – P. 3969-3972.51Sproat B.S., Agraval S., In Methods in Molecular Biology. Protocols forOligonucleotides and Analogs. Synthesis and Properties // Ed.
Humana, TotowaN.J. – 1993. – V. 20. – P. 115–141.52Hovinen J., Azhayeva E., Azhayev A., Guzaev A., Lonnberg H.J. Synthesis of3’-O-(ω-aminoalkoxymethyl)thymidine 5’-triphosphates, terminators of DNA145synthesis that enable 3’-labelling // Chem. Soc. Perkin Trans. – 1994. – V. 1. – P.211– 217.53Bednarska K., Olejniczak A.B., Piskala A., Klink M., Sulowska Z., LesnikowskiZ.J. Effect of adenosine modified with a boron cluster pharmacophore on reactiveoxygen species production by human neutrophils // Bioorg.
Med. Chem. – 2012. –V. 20. – P. 6621–6629.54Wojtczak B.A., Olejniczak A.B., Lesnikowski Z.J. Nucleoside Modificationwith Boron Clusters and Their Metal Complexes // Curr. Protoc. Nucleic AcidChem. – 2009. – V.4. – P. 4.37.1-4.37.26.55Olejniczak A., Wojtczak B., Lesnikowski Z.J. 2’-Deoxyadenosine BearingHydrophobic Carborane Pharmacophore // Nucleosides, Nucleotides NucleicAcids. – 2012.
– V. 26. – P. 611–1613.56Ikehara M., Kaneko M. Studies of nucleosides and nucleotides. Purinecyclonucleosides. Synthesis of cyclonucleosides having 8,3-O- and S-anhydrolinkage derived from 2-deoxyadenosine // Chem. Pharm. Bull. – 1970. – V.
18. –P. 2441–2446.57W. Jiang, Knobler C.B., Curtis C.E., Mortimer M.D., Hawthorne M.F.Iodination reactions of icosahedral para-carborane and the synthesis of carboranederivatives with boron-carbon bonds // Inorg. Chem. – 1995. – V. 34. – P. 34913498.58Robins M.J., Uznanski B. Method for the preparation of 2-halo-2’-deoxyadenosine compounds from 2’-deoxyguanosine // Can.
J. Chem. – 1981. – V.59. – P. 2601-2607.59Wilson J.G., Anisuzzaman A.K.M., Alam F., Soloway A.H. Development ofcarborane synthons: synthesis and chemistry of (aminoalkyl)carboranes // Inorg.Chem. –1992. – V. 31. – P. 1955-1958.60Olejniczak A.B., Semenuk A., Kwiatkowski M., Lesnikowski Z.J. Synthesis ofadenosine containing carborane modification// J. Organomet.Chem. – 2003. – V.680. – P.
124-126.14661Jaakkola L., Peuralahti J., Hakala H., Kunttu J., Tallqvist P., Mukkala V.M.,Ylikoski A., Hovinen J. Solid-Phase Synthesis of Oligonucleotides Labeled withLuminescent Lanthanide(lll) Chelates // Bioconjugate Chem. – 2005. – V. 16. – P.700-709.62Jaakkola L., Peuralahti J., Hakala H., Kunttu J., Tallqvist P., Mukkala V.M.,Ylikoski A., Hovinene J., Olejniczak A.B., Sut A., Wroblewski A.E., LesnikowskiZ.J. Infrared spectroscopy of nucleoside and DNA-oligonucleotide conjugateslabeled with carborane or metallacarborane cage // Vib.
Spectrosc. – 2005. – V. 39.– P. 177-185.63Younes C., Boisgard R., Tavitian B. Labelled oligonucleotides asradiopharmaceuticals: pitfalls, problems and perspectives // Curr. Pharm. Des. –2002. – V. 8. – P. 1451-1466.64NunezM.E.,BartonJ.K.ProbingDNAchargetransportwithmetallointercalators // Curr.Opin. Chem. Biol. – 2000. – V. 4. – P. 199-206.65Lešnikowski Z.J., Paradowska E., Olejniczak A.B., Studzińska M., Seekamp P.,Schüßler U., Gabel D., Schinazi R.F., Plešek J. Towards new boron carriers forboron neutron capture therapy: metallacarboranes and their nucleoside conjugates// Bioorg. Med.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
